Figure 1.
The change in estimated glomerular filtration rate (eGFR) and the possible mechanisms for improvement in heart failure due to sodium-glucose cotransporter 2 inhibitors (SGLT2i). The graph was modified from Figure 1 in (9).
The change in estimated glomerular filtration rate (eGFR) and the possible mechanisms for improvement in heart failure due to sodium-glucose cotransporter 2 inhibitors (SGLT2i). The graph was modified from Figure 1 in (9).